2
Clinical Trials associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)A Randomized, Blinded, Parallel Controlled Phase 3 Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People Aged 2 Years and Above
This study is a randomized, blinded, parallel controlled phase 3 clinical trial to evaluate the immunogenicity and safety of the 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and above.
/ Active, not recruitingPhase 1 评价23价肺炎球菌多糖疫苗在2岁及以上人群接种的安全性和免疫原性的单中心、开放Ⅰ期临床试验
[Translation] A single-center, open-label phase I clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in people aged 2 years and above
主要目的:评价在2岁及以上人群中接种1剂23价肺炎球菌多糖疫苗的安全性。
次要目的:初步评价在2岁及以上人群中接种1剂23价肺炎球菌多糖疫苗的免疫原性。
[Translation] Primary objective: To evaluate the safety of 1 dose of 23-valent pneumococcal polysaccharide vaccine in people aged 2 years and above.
Secondary objective: To preliminarily evaluate the immunogenicity of 1 dose of 23-valent pneumococcal polysaccharide vaccine in people aged 2 years and above.
100 Clinical Results associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)
100 Translational Medicine associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)
100 Patents (Medical) associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)
100 Deals associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)